These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30263059)

  • 1. Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment.
    Pouncey AL; Scott AJ; Alexander JL; Marchesi J; Kinross J
    Ecancermedicalscience; 2018; 12():868. PubMed ID: 30263059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota Shapes the Efficiency of Cancer Therapy.
    Ma W; Mao Q; Xia W; Dong G; Yu C; Jiang F
    Front Microbiol; 2019; 10():1050. PubMed ID: 31293523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota modulation of chemotherapy efficacy and toxicity.
    Alexander JL; Wilson ID; Teare J; Marchesi JR; Nicholson JK; Kinross JM
    Nat Rev Gastroenterol Hepatol; 2017 Jun; 14(6):356-365. PubMed ID: 28270698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the gut microbiota to alleviate chemotherapy-induced toxicity in cancer.
    Xu Y; Du H; Chen Y; Ma C; Zhang Q; Li H; Xie Z; Hong Y
    Crit Rev Microbiol; 2023 Jul; ():1-17. PubMed ID: 37439132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota in cancer development and treatment.
    Raza MH; Gul K; Arshad A; Riaz N; Waheed U; Rauf A; Aldakheel F; Alduraywish S; Rehman MU; Abdullah M; Arshad M
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):49-63. PubMed ID: 30542789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy.
    Yue B; Gao R; Wang Z; Dou W
    Front Cell Infect Microbiol; 2021; 11():710945. PubMed ID: 34722328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of gut microbiota and metabolites in cancer chemotherapy.
    Li S; Zhu S; Yu J
    J Adv Res; 2023 Nov; ():. PubMed ID: 38013112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic cell death: A link between gut microbiota and anticancer effects.
    Chen W; Wang S; Wu Y; Shen X; Guo Z; Li Q; Xing D
    Microb Pathog; 2020 Apr; 141():103983. PubMed ID: 31954823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity.
    Cario E
    Curr Opin Support Palliat Care; 2016 Jun; 10(2):157-64. PubMed ID: 26986508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?
    Villéger R; Lopès A; Carrier G; Veziant J; Billard E; Barnich N; Gagnière J; Vazeille E; Bonnet M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy.
    Gori S; Inno A; Belluomini L; Bocus P; Bisoffi Z; Russo A; Arcaro G
    Crit Rev Oncol Hematol; 2019 Nov; 143():139-147. PubMed ID: 31634731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microbiome and precision oncology: an emerging paradigm in anticancer therapy.
    Bhat SA; Kaur R; Chauhan A; Pal A
    Crit Rev Microbiol; 2022 Nov; 48(6):770-783. PubMed ID: 35164642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease.
    Chen YY; Chen DQ; Chen L; Liu JR; Vaziri ND; Guo Y; Zhao YY
    J Transl Med; 2019 Jan; 17(1):5. PubMed ID: 30602367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic role of the gut microbiota in gastrointestinal diseases.
    Nagao-Kitamoto H; Kitamoto S; Kuffa P; Kamada N
    Intest Res; 2016 Apr; 14(2):127-38. PubMed ID: 27175113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiome in chronic kidney disease: challenges and opportunities.
    Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D
    Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential.
    Saus E; Iraola-Guzmán S; Willis JR; Brunet-Vega A; Gabaldón T
    Mol Aspects Med; 2019 Oct; 69():93-106. PubMed ID: 31082399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
    Hekmatshoar Y; Rahbar Saadat Y; Hosseiniyan Khatibi SM; Ozkan T; Zununi Vahed F; Nariman-Saleh-Fam Z; Pourghassem Gargari B; Sunguroglu A; Zununi Vahed S
    Life Sci; 2019 Sep; 233():116680. PubMed ID: 31344431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of gut microbiota on neuropsychiatric disorders.
    Cenit MC; Sanz Y; Codoñer-Franch P
    World J Gastroenterol; 2017 Aug; 23(30):5486-5498. PubMed ID: 28852308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy.
    Zhang X; Liu Q; Liao Q; Zhao Y
    J Cancer; 2020; 11(10):2749-2758. PubMed ID: 32226493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Microbiome in Immuno-oncology.
    Toker J; Arora R; Wargo JA
    Adv Exp Med Biol; 2020; 1244():325-334. PubMed ID: 32301026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.